TCTAP 2026 Sponsors

Sanofi-Aventis Korea

Logo
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi-aventis Korea has maintained its certification as Family Friendly Company since 2013 and its accreditation as Innovative Pharmaceutical Company since 2014. We are in Korea committed to working with local pharmaceutical companies, bio-techs, clinical research centers as well as academia in Korea to bring innovation where high unmet patient needs exist.

Exhibition Item

Plavix, Praluent

Satellite Symposium

AI Translations icon AI Translations

Lunchtime Activities

Comprehensive Management Strategies for ACS Patients: Advanced Antiplatelet and Lipid Therapies

Organized by CVRF and Supported by Educational Grant From Sanofi Korea

Thursday, April 30
12:20 PM ~ 1:20 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
12:20 PM Opening Remarks
12:25 PM Clopidogrel: Advanced Antiplatelet Therapy in ACS Patients With Long-Term Management
Lecturer: Do-Yoon Kang
12:45 PM Alirocumab: Advanced LDL-C Management in ACS Patients With Early and Intensive Control
Lecturer: Ju Seung Kwun
1:05 PM Discussion